Doxorubicin and erastin co-loaded hydroxyethyl starch-polycaprolactone nanoparticles for synergistic cancer therapy

C Xu, S Li, J Chen, H Wang, Z Li, Q Deng, J Li… - Journal of Controlled …, 2023 - Elsevier
Cancer stem cells (CSCs), enabled to self-renew, differentiate, and initiate the bulk tumor,
are recognized as the culprit of treatment resistance, metastasis, and recurrence …

Curcumin loaded selenium nanoparticles synergize the anticancer potential of doxorubicin contained in self-assembled, cell receptor targeted nanoparticles

M Kumari, MP Purohit, S Patnaik, Y Shukla… - European Journal of …, 2018 - Elsevier
Doxorubicin (DOX) has been extensively used to treat a wide range of cancers in free and
nanotized form. Nanotization of DOX has alleviated its toxicity and efflux-mediated …

Breaking the intracellular redox balance with diselenium nanoparticles for maximizing chemotherapy efficacy on patient-derived xenograft models

D Wei, Y Yu, X Zhang, Y Wang, H Chen, Y Zhao… - ACS …, 2020 - ACS Publications
Excessive oxidative stress in cancer cells can induce cancer cell death. Anticancer activity
and drug resistance of chemotherapy are closely related to the redox state of tumor cells …

pH and redox dual-responsive nanoparticles based on disulfide-containing poly (β-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug …

S Zhang, N Guo, G Wan, T Zhang, C Li, Y Wang… - Journal of …, 2019 - Springer
Background Multidrug resistance (MDR) generally leads to breast cancer treatment failure.
The most common mechanism of MDR is the overexpression of ATP-binding cassette (ABC) …

Redox‐responsive dual drug delivery nanosystem suppresses cancer repopulation by abrogating doxorubicin‐promoted cancer stemness, metastasis, and drug …

J Liu, B Chang, Q Li, L Xu, X Liu, G Wang… - Advanced …, 2019 - Wiley Online Library
Chemotherapy is a major therapeutic option for cancer patients. However, its effectiveness is
challenged by chemodrugs' intrinsic pathological interactions with residual cancer cells …

pH-responsive selenium nanoparticles stabilized by folate-chitosan delivering doxorubicin for overcoming drug-resistant cancer cells

U Luesakul, S Puthong, N Neamati, N Muangsin - Carbohydrate polymers, 2018 - Elsevier
Herein, we first report pH-responsive SeNPs stabilized with modified folic acid-N-trimethyl
chitosan (TMC-FA) as nanocarriers for delivery of doxorubicin (DOX) to overcome drug …

Synergistic combination chemotherapy using carrier-free celastrol and doxorubicin nanocrystals for overcoming drug resistance

Y Xiao, J Liu, M Guo, H Zhou, J Jin, J Liu, Y Liu… - Nanoscale, 2018 - pubs.rsc.org
A key challenge of chemotherapy in clinical treatments is multidrug resistance (MDR), which
mainly arises from drug efflux-induced tumor cell survival. Thus, it is necessary to provide …

Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance

Y Zhao, M Huan, M Liu, Y Cheng, Y Sun, H Cui, D Liu… - Scientific reports, 2016 - nature.com
With the extensive application of doxorubicin (DOX), DOX resistance has become one of the
main obstacles to the effective treatment of breast cancer. In this paper, DOX and resveratrol …

A novel ROS-activable self-immolative prodrug for tumor-specific amplification of oxidative stress and enhancing chemotherapy of mitoxantrone

H Zhang, W Chen, J Wang, W Du, B Wang, L Song… - Biomaterials, 2023 - Elsevier
Reactive oxygen species (ROS) as well-known endogenous stimuli has been widely used to
activate drug delivery systems (DDSs) for tumor-specific therapy. Unfortunately, endogenous …

[HTML][HTML] Enhancing therapeutic effects of docetaxel-loaded dendritic copolymer nanoparticles by co-treatment with autophagy inhibitor on breast cancer

X Zhang, Y Yang, X Liang, X Zeng, Z Liu, W Tao… - Theranostics, 2014 - ncbi.nlm.nih.gov
Dendrimers are synthetic nanocarriers that comprise a highly branched spherical polymer
as new, efficient tools for drug delivery. However, the fate of nanocarriers after being …